EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.

MLA

Achounna, Angèle Sorel, et al. “EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.” International Journal of Molecular Sciences, vol. 25, no. 6, Mar. 2024, p. 3165. EBSCOhost, https://doi.org/10.3390/ijms25063165.

APA

Achounna, A. S., Ordaz-Rosado, D., García-Quiroz, J., Morales-Guadarrama, G., Milo-Rocha, E., Larrea, F., Díaz, L., & García-Becerra, R. (2024). EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells. International Journal of Molecular Sciences, 25(6), 3165. https://doi.org/10.3390/ijms25063165

Chicago

Achounna, Angèle Sorel, David Ordaz-Rosado, Janice García-Quiroz, Gabriela Morales-Guadarrama, Edgar Milo-Rocha, Fernando Larrea, Lorenza Díaz, and Rocío García-Becerra. 2024. “EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.” International Journal of Molecular Sciences 25 (6): 3165. doi:10.3390/ijms25063165.